首页 > 最新文献

The Journal of pediatric endocrinology最新文献

英文 中文
Growth hormone (GH) and the immune system: impaired phagocytic function in children with idiopathic GH deficiency is corrected by treatment with biosynthetic GH. 生长激素(GH)和免疫系统:特发性GH缺乏儿童的吞噬功能受损可通过生物合成GH治疗得到纠正。
Pub Date : 1994-07-01 DOI: 10.1515/jpem.1994.7.3.245
R Manfredi, F Tumietto, L Azzaroli, A Zucchini, F Chiodo, G Manfredi

Thirty-seven prepubertal children evaluated for severe growth retardation were studied by assessment of total granulocyte, monocyte and lymphocyte count, lymphocyte subsets CD3+, CD3+Dr+, CD3+Dr-, CD4+, CD8+, CD8+CD57+, CD8+CD57-, CD16+, CD20+ and CD23+, serum immunoglobulin concentrations, and phagocytic activity of circulating neutrophils and monocytes (by a flow cytometric assay). Idiopathic GH deficiency was diagnosed in 21 of 37 patients; the remaining 16 healthy subjects served as controls. Fourteen patients received biosynthetic GH (rhGH), and their immune parameters were assessed at baseline and after 6 months of therapy. Phagocytic function mediated by both polymorphonuclears and monocytes was significantly impaired in GH-deficient subjects compared to controls (p < 0.003 for neutrophils, p < 0.007 for monocytes), while a significant increase of phagocytic activity was obtained during long-term rhGH replacement therapy (p < 0.02 for neutrophils, p < 0.001 for monocytes), thus suggesting that GH may affect the functional activity of circulating phagocyte cells. No significant differences were found in total granulocyte, monocyte and lymphocyte counts, T- and B-lymphocyte subsets and immunoglobulin levels, between GH-deficient patients and controls, and between values observed before and during rhGH substitution treatment.

通过评估粒细胞总数、单核细胞和淋巴细胞计数、淋巴细胞亚群CD3+、CD3+Dr+、CD3+Dr-、CD4+、CD8+、CD8+CD57+、CD8+CD57-、CD16+、CD20+和CD23+、血清免疫球蛋白浓度以及循环中性粒细胞和单核细胞的吞噬活性(流式细胞术测定),对37例重度生长迟缓的青春期前儿童进行了研究。37例患者中有21例诊断为特发性生长激素缺乏;其余16名健康受试者作为对照。14例患者接受生物合成生长激素(rhGH)治疗,并在基线和治疗6个月后评估其免疫参数。与对照组相比,GH缺陷患者多形核和单核细胞介导的吞噬功能明显受损(中性粒细胞p < 0.003,单核细胞p < 0.007),而在长期rhGH替代治疗期间,吞噬活性显著增加(中性粒细胞p < 0.02,单核细胞p < 0.001),这表明GH可能影响循环吞噬细胞的功能活性。在gh缺陷患者和对照组之间,以及在rhGH替代治疗前和期间观察到的数值之间,在总粒细胞、单核细胞和淋巴细胞计数、T和b淋巴细胞亚群和免疫球蛋白水平方面均未发现显著差异。
{"title":"Growth hormone (GH) and the immune system: impaired phagocytic function in children with idiopathic GH deficiency is corrected by treatment with biosynthetic GH.","authors":"R Manfredi,&nbsp;F Tumietto,&nbsp;L Azzaroli,&nbsp;A Zucchini,&nbsp;F Chiodo,&nbsp;G Manfredi","doi":"10.1515/jpem.1994.7.3.245","DOIUrl":"https://doi.org/10.1515/jpem.1994.7.3.245","url":null,"abstract":"<p><p>Thirty-seven prepubertal children evaluated for severe growth retardation were studied by assessment of total granulocyte, monocyte and lymphocyte count, lymphocyte subsets CD3+, CD3+Dr+, CD3+Dr-, CD4+, CD8+, CD8+CD57+, CD8+CD57-, CD16+, CD20+ and CD23+, serum immunoglobulin concentrations, and phagocytic activity of circulating neutrophils and monocytes (by a flow cytometric assay). Idiopathic GH deficiency was diagnosed in 21 of 37 patients; the remaining 16 healthy subjects served as controls. Fourteen patients received biosynthetic GH (rhGH), and their immune parameters were assessed at baseline and after 6 months of therapy. Phagocytic function mediated by both polymorphonuclears and monocytes was significantly impaired in GH-deficient subjects compared to controls (p < 0.003 for neutrophils, p < 0.007 for monocytes), while a significant increase of phagocytic activity was obtained during long-term rhGH replacement therapy (p < 0.02 for neutrophils, p < 0.001 for monocytes), thus suggesting that GH may affect the functional activity of circulating phagocyte cells. No significant differences were found in total granulocyte, monocyte and lymphocyte counts, T- and B-lymphocyte subsets and immunoglobulin levels, between GH-deficient patients and controls, and between values observed before and during rhGH substitution treatment.</p>","PeriodicalId":79383,"journal":{"name":"The Journal of pediatric endocrinology","volume":"7 3","pages":"245-51"},"PeriodicalIF":0.0,"publicationDate":"1994-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/jpem.1994.7.3.245","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18819151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 36
Abnormal alpha cell hypoglycemic recognition in children with insulin dependent diabetes mellitus (IDDM). 胰岛素依赖型糖尿病(IDDM)患儿α细胞低血糖识别异常。
Pub Date : 1994-07-01 DOI: 10.1515/jpem.1994.7.3.225
R P Hoffman, C Singer-Granick, A L Drash, D J Becker

Children with IDDM have diminished glucagon responses to hypoglycemia. We evaluated possible mechanisms in 60 children and adolescents with IDDM (age 15.4 +/- 2.6 years, duration 7.8 +/- 3.5 years [mean +/- SD]) and without diabetic complications. These were: 1) suppression by hyperinsulinism, 2) autonomic neuropathy, 3) a pan-islet cell defect, and 4) a glucotoxic effect. Glucagon and pancreatic polypeptide responses to hypoglycemia (insulin bolus 0.15-0.75 U/kg) were studied after insulin withdrawal and 3 days of intensive insulin therapy. Responses to arginine and mixed meal were also studied. The control group consisted of children with non-growth hormone deficient short stature. IDDM children had lower glucagon responses to hypoglycemia than controls (p < 0.001), the response to arginine did not differ from controls, and was greater than the response to hypoglycemia (p < 0.001). Responses to hypoglycemia after insulin withdrawal and intensive therapy did not differ. Basal pancreatic polypeptide levels were lower in IDDM than in controls (p < 0.05) but responses to hypoglycemia did not differ between groups. Thus the diminished glucagon response to hypoglycemia reflects a defect in hypoglycemic recognition or response by the alpha cells.

IDDM患儿胰高血糖素对低血糖的反应减弱。我们评估了60例无糖尿病并发症的IDDM儿童和青少年(年龄15.4 +/- 2.6岁,病程7.8 +/- 3.5年[平均+/- SD])可能的发病机制。这些是:1)高胰岛素抑制,2)自主神经病变,3)泛胰岛细胞缺陷,4)糖毒性作用。在胰岛素停药和胰岛素强化治疗3天后,研究胰高血糖素和胰多肽对低血糖(胰岛素剂量0.15 ~ 0.75 U/kg)的反应。对精氨酸和混合饲料的反应也进行了研究。对照组由非生长激素缺乏的矮小儿童组成。IDDM患儿对低血糖的胰高血糖素反应低于对照组(p < 0.001),对精氨酸的反应与对照组无差异,且高于对低血糖的反应(p < 0.001)。胰岛素停药和强化治疗后对低血糖的反应没有差异。IDDM患者的基础胰多肽水平低于对照组(p < 0.05),但两组之间对低血糖的反应没有差异。因此,胰高血糖素对低血糖反应的减弱反映了α细胞对低血糖识别或反应的缺陷。
{"title":"Abnormal alpha cell hypoglycemic recognition in children with insulin dependent diabetes mellitus (IDDM).","authors":"R P Hoffman,&nbsp;C Singer-Granick,&nbsp;A L Drash,&nbsp;D J Becker","doi":"10.1515/jpem.1994.7.3.225","DOIUrl":"https://doi.org/10.1515/jpem.1994.7.3.225","url":null,"abstract":"<p><p>Children with IDDM have diminished glucagon responses to hypoglycemia. We evaluated possible mechanisms in 60 children and adolescents with IDDM (age 15.4 +/- 2.6 years, duration 7.8 +/- 3.5 years [mean +/- SD]) and without diabetic complications. These were: 1) suppression by hyperinsulinism, 2) autonomic neuropathy, 3) a pan-islet cell defect, and 4) a glucotoxic effect. Glucagon and pancreatic polypeptide responses to hypoglycemia (insulin bolus 0.15-0.75 U/kg) were studied after insulin withdrawal and 3 days of intensive insulin therapy. Responses to arginine and mixed meal were also studied. The control group consisted of children with non-growth hormone deficient short stature. IDDM children had lower glucagon responses to hypoglycemia than controls (p < 0.001), the response to arginine did not differ from controls, and was greater than the response to hypoglycemia (p < 0.001). Responses to hypoglycemia after insulin withdrawal and intensive therapy did not differ. Basal pancreatic polypeptide levels were lower in IDDM than in controls (p < 0.05) but responses to hypoglycemia did not differ between groups. Thus the diminished glucagon response to hypoglycemia reflects a defect in hypoglycemic recognition or response by the alpha cells.</p>","PeriodicalId":79383,"journal":{"name":"The Journal of pediatric endocrinology","volume":"7 3","pages":"225-34"},"PeriodicalIF":0.0,"publicationDate":"1994-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/jpem.1994.7.3.225","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18820618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 17
Adult height exceeding target height in a patient with congenital panhypopituitarism diagnosed after the age of 25 years. 25岁以后诊断为先天性垂体功能减退症的成人身高超过目标身高1例。
Pub Date : 1994-07-01 DOI: 10.1515/jpem.1994.7.3.269
T Arrigo, G Crisafulli, A Salamone, D Cucinotta, F De Luca

This case report concerns a prepubertal patient (height 148.7 cm) with congenital anterior panhypopituitarism diagnosed at the chronological age of 25.2 years (bone age 12.5). In spite of his advanced age on initiation of hormonal replacement therapy this patient achieved an adult height (172.8 cm), exceeding those of his father and brothers, because of his markedly delayed bone age. This satisfactory height outcome confirms that final height in hypopituitarism depends on both height at onset of puberty and height with respect to bone age but not chronological age at initiation of growth hormone treatment.

本病例报告涉及一名青春期前患者(身高148.7 cm),在实足年龄25.2岁(骨年龄12.5岁)时被诊断为先天性前垂体功能减退症。尽管在开始激素替代治疗时,患者已年事已高,但由于骨龄明显延迟,患者达到了成人身高(172.8 cm),超过了他的父亲和兄弟。这一令人满意的身高结果证实,垂体功能减退症的最终身高取决于青春期开始时的身高和与骨龄相关的身高,而不是生长激素治疗开始时的实足年龄。
{"title":"Adult height exceeding target height in a patient with congenital panhypopituitarism diagnosed after the age of 25 years.","authors":"T Arrigo,&nbsp;G Crisafulli,&nbsp;A Salamone,&nbsp;D Cucinotta,&nbsp;F De Luca","doi":"10.1515/jpem.1994.7.3.269","DOIUrl":"https://doi.org/10.1515/jpem.1994.7.3.269","url":null,"abstract":"<p><p>This case report concerns a prepubertal patient (height 148.7 cm) with congenital anterior panhypopituitarism diagnosed at the chronological age of 25.2 years (bone age 12.5). In spite of his advanced age on initiation of hormonal replacement therapy this patient achieved an adult height (172.8 cm), exceeding those of his father and brothers, because of his markedly delayed bone age. This satisfactory height outcome confirms that final height in hypopituitarism depends on both height at onset of puberty and height with respect to bone age but not chronological age at initiation of growth hormone treatment.</p>","PeriodicalId":79383,"journal":{"name":"The Journal of pediatric endocrinology","volume":"7 3","pages":"269-72"},"PeriodicalIF":0.0,"publicationDate":"1994-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/jpem.1994.7.3.269","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18819088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Impaired counterregulatory hormone responses to hypoglycemia in children and adolescents with new onset IDDM. 新发IDDM儿童和青少年对低血糖的反调节激素反应受损。
Pub Date : 1994-07-01 DOI: 10.1515/jpem.1994.7.3.235
R P Hoffman, S Arslanian, A L Drash, D J Becker

Children with long-standing IDDM have impaired counterregulatory responses to hypoglycemia. To determine whether children with new onset IDDM also have altered counterregulation, we studied the counterregulatory responses to hypoglycemia in twenty children with new onset IDDM (5-6 days, age 12.6 +/- 2.9 yr, mean +/- SD), and compared these responses to 47 subjects with long-standing IDDM (duration 7.8 +/- 3.6 yr, age 15.3 +/- 2.5 yr) and 21 controls (age 14.2 +/- 2.8 yr). Six new onset subjects were restudied three months later during their remission. Glucose nadir in new onset (2.7 +/- 0.1 mmol.l-1) was similar to controls (2.4 +/- 0.1 mmol.l-1), but was higher than in long-standing IDDM (2.2 +/- 0.1 mmol.l-1). Both groups of diabetic subjects had lower glucagon responses to hypoglycemia than controls (p < 0.005). Glucagon responses in new and long-standing diabetes did not differ. Epinephrine was diminished in new IDDM compared to controls (p < 0.01). Glucose recovery was faster in new onset than in long-standing IDDM (p < 0.001) and the same as in controls. Responses remained diminished 3 months after diagnosis despite increased C-peptide and lower glycosylated hemoglobin. Thus, children with IDDM have diminished counterregulatory responses to hypoglycemia at diagnosis, that are similar to those in long-standing IDDM. The reasons for this impairment and its clinical application in childhood require further investigation.

长期患有IDDM的儿童对低血糖的反调节反应受损。为了确定新发IDDM儿童是否也有改变的反调节,我们研究了20名新发IDDM儿童(5-6天,年龄12.6 +/- 2.9年,平均+/- SD)对低血糖的反调节反应,并将这些反应与47名长期IDDM患者(持续时间7.8 +/- 3.6年,年龄15.3 +/- 2.5年)和21名对照组(年龄14.2 +/- 2.8年)进行了比较。六个新发病的受试者在缓解期三个月后重新研究。新发病患者的血糖最低点(2.7 +/- 0.1 mmol.l-1)与对照组(2.4 +/- 0.1 mmol.l-1)相似,但高于长期IDDM患者(2.2 +/- 0.1 mmol.l-1)。两组糖尿病患者对低血糖的胰高血糖素反应均低于对照组(p < 0.005)。新发糖尿病和长期糖尿病的胰高血糖素反应没有差异。与对照组相比,新发IDDM患者肾上腺素水平降低(p < 0.01)。新发IDDM患者的血糖恢复速度快于长期IDDM患者(p < 0.001),与对照组相同。诊断后3个月,尽管c肽升高,糖化血红蛋白降低,但反应仍然减弱。因此,IDDM患儿在诊断时对低血糖的反调节反应减弱,这与长期IDDM患者相似。这种损伤的原因及其在儿童中的临床应用需要进一步研究。
{"title":"Impaired counterregulatory hormone responses to hypoglycemia in children and adolescents with new onset IDDM.","authors":"R P Hoffman,&nbsp;S Arslanian,&nbsp;A L Drash,&nbsp;D J Becker","doi":"10.1515/jpem.1994.7.3.235","DOIUrl":"https://doi.org/10.1515/jpem.1994.7.3.235","url":null,"abstract":"<p><p>Children with long-standing IDDM have impaired counterregulatory responses to hypoglycemia. To determine whether children with new onset IDDM also have altered counterregulation, we studied the counterregulatory responses to hypoglycemia in twenty children with new onset IDDM (5-6 days, age 12.6 +/- 2.9 yr, mean +/- SD), and compared these responses to 47 subjects with long-standing IDDM (duration 7.8 +/- 3.6 yr, age 15.3 +/- 2.5 yr) and 21 controls (age 14.2 +/- 2.8 yr). Six new onset subjects were restudied three months later during their remission. Glucose nadir in new onset (2.7 +/- 0.1 mmol.l-1) was similar to controls (2.4 +/- 0.1 mmol.l-1), but was higher than in long-standing IDDM (2.2 +/- 0.1 mmol.l-1). Both groups of diabetic subjects had lower glucagon responses to hypoglycemia than controls (p < 0.005). Glucagon responses in new and long-standing diabetes did not differ. Epinephrine was diminished in new IDDM compared to controls (p < 0.01). Glucose recovery was faster in new onset than in long-standing IDDM (p < 0.001) and the same as in controls. Responses remained diminished 3 months after diagnosis despite increased C-peptide and lower glycosylated hemoglobin. Thus, children with IDDM have diminished counterregulatory responses to hypoglycemia at diagnosis, that are similar to those in long-standing IDDM. The reasons for this impairment and its clinical application in childhood require further investigation.</p>","PeriodicalId":79383,"journal":{"name":"The Journal of pediatric endocrinology","volume":"7 3","pages":"235-44"},"PeriodicalIF":0.0,"publicationDate":"1994-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/jpem.1994.7.3.235","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18819152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 23
Thyroid function in children with perinatally acquired antibodies to human immunodeficiency virus. 围产期获得性人类免疫缺陷病毒抗体儿童的甲状腺功能。
Pub Date : 1994-07-01 DOI: 10.1515/jpem.1994.7.3.201
S L Blethen, S Nachman, F I Chasalow

We measured T4, T3, TSH, and TBG in 53 children (both asymptomatic and symptomatic) with human immunodeficiency virus (HIV) antibodies, and 17 controls. Although most had normal T3 and T4 levels, two children with acquired immuno-deficiency syndrome (AIDS), who were very ill when studied, had low T3 values. TBG and TSH levels were higher in children with AIDS than in other HIV-infected children or controls (P < 0.005). Increased TSH levels were found in 5 children with AIDS who were recovering from severe illnesses. TSH levels returned to normal without treatment. In summary: 1) the pattern of thyroid abnormalities in children with AIDS was different from that seen in healthy controls, critically ill children, other HIV-infected children, and HIV-infected adults; 2) if an increased TSH is found, measurement should be repeated before instituting thyroxine therapy; 3) an increased TBG is not seen in HIV-infected children until clinically evident AIDS is present.

我们测量了53例(无症状和有症状)人类免疫缺陷病毒(HIV)抗体儿童的T4、T3、TSH和TBG,以及17例对照。虽然大多数人的T3和T4水平正常,但两名患有获得性免疫缺陷综合征(AIDS)的儿童的T3值较低,他们在研究时病情严重。艾滋病患儿的TBG和TSH水平高于其他hiv感染患儿或对照组(P < 0.005)。在5名患有艾滋病的儿童中发现TSH水平升高,这些儿童正在从严重疾病中恢复。未经治疗,TSH水平恢复正常。综上所述:1)艾滋病儿童的甲状腺异常模式不同于健康对照、危重儿童、其他艾滋病毒感染儿童和艾滋病毒感染成人;2)如果发现TSH升高,在开始甲状腺素治疗前应重复测量;3)在临床表现明显的艾滋病出现之前,在hiv感染儿童中看不到TBG升高。
{"title":"Thyroid function in children with perinatally acquired antibodies to human immunodeficiency virus.","authors":"S L Blethen,&nbsp;S Nachman,&nbsp;F I Chasalow","doi":"10.1515/jpem.1994.7.3.201","DOIUrl":"https://doi.org/10.1515/jpem.1994.7.3.201","url":null,"abstract":"<p><p>We measured T4, T3, TSH, and TBG in 53 children (both asymptomatic and symptomatic) with human immunodeficiency virus (HIV) antibodies, and 17 controls. Although most had normal T3 and T4 levels, two children with acquired immuno-deficiency syndrome (AIDS), who were very ill when studied, had low T3 values. TBG and TSH levels were higher in children with AIDS than in other HIV-infected children or controls (P < 0.005). Increased TSH levels were found in 5 children with AIDS who were recovering from severe illnesses. TSH levels returned to normal without treatment. In summary: 1) the pattern of thyroid abnormalities in children with AIDS was different from that seen in healthy controls, critically ill children, other HIV-infected children, and HIV-infected adults; 2) if an increased TSH is found, measurement should be repeated before instituting thyroxine therapy; 3) an increased TBG is not seen in HIV-infected children until clinically evident AIDS is present.</p>","PeriodicalId":79383,"journal":{"name":"The Journal of pediatric endocrinology","volume":"7 3","pages":"201-4"},"PeriodicalIF":0.0,"publicationDate":"1994-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/jpem.1994.7.3.201","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18820614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Neonatal sex-steroid hormones and physical size at four years. 新生儿四岁时的性类固醇激素和体格大小。
Pub Date : 1994-07-01 DOI: 10.1515/jpem.1994.7.3.253
C N Jacklin, C McBride, P McCrory, L Gallahan

This study investigated the relationships of neonatal sex-steroid hormones to preschool children's size. Two measures of size were considered: a unidimensional measure of height and a weight-for-height ratio. Results showed a significant positive relationship between girls' neonatal progesterone and the weight-for-height ratio at age four. A negative association of this ratio with an estrogen composite measure was also found. High testosterone girls had higher weight-for-height ratios than low testosterone girls. A significant positive association between the estrogen composite and height was found for boys. These findings indicate that neonatal hormone levels are important complements to environmental factors (e.g., nutrition) in predicting later growth.

本研究旨在探讨新生儿性类固醇激素与学龄前儿童体型的关系。考虑了两种尺寸度量:一维的身高度量和身高体重比。结果显示,女童4岁时新生儿孕酮水平与体重身高比呈正相关。该比率与雌激素综合测量呈负相关。睾丸激素水平高的女孩比睾丸激素水平低的女孩体重身高比更高。在男孩中,雌激素复合物与身高之间存在显著的正相关。这些发现表明,新生儿激素水平是预测后期生长的环境因素(如营养)的重要补充。
{"title":"Neonatal sex-steroid hormones and physical size at four years.","authors":"C N Jacklin,&nbsp;C McBride,&nbsp;P McCrory,&nbsp;L Gallahan","doi":"10.1515/jpem.1994.7.3.253","DOIUrl":"https://doi.org/10.1515/jpem.1994.7.3.253","url":null,"abstract":"<p><p>This study investigated the relationships of neonatal sex-steroid hormones to preschool children's size. Two measures of size were considered: a unidimensional measure of height and a weight-for-height ratio. Results showed a significant positive relationship between girls' neonatal progesterone and the weight-for-height ratio at age four. A negative association of this ratio with an estrogen composite measure was also found. High testosterone girls had higher weight-for-height ratios than low testosterone girls. A significant positive association between the estrogen composite and height was found for boys. These findings indicate that neonatal hormone levels are important complements to environmental factors (e.g., nutrition) in predicting later growth.</p>","PeriodicalId":79383,"journal":{"name":"The Journal of pediatric endocrinology","volume":"7 3","pages":"253-9"},"PeriodicalIF":0.0,"publicationDate":"1994-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/jpem.1994.7.3.253","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18819155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Growth follow-up in 100 children with congenital hypothyroidism before and during treatment. 100例先天性甲状腺功能减退症患儿治疗前后的生长随访。
Pub Date : 1994-07-01 DOI: 10.1515/jpem.1994.7.3.211
A Chiesa, L Gruñeiro de Papendieck, A Keselman, J J Heinrich, C Bergada
In order to assess the influence of age at onset of treatment on subsequent growth, height, weight, head circumference (HC) and bone age as estimated by Greulich-Pyle and TW2-RUS methods, 100 children with congenital hypothyroidism (CH) were studied before and during adequate treatment up to 5 years of age. The patients were divided into five groups according to age at the start of treatment: Group 1: < 2 months (n = 26); Group 2: 2-3 months (n = 13); Group 3: 3-6 months (n = 21); Group 4: 6-12 months (n = 20); Group 5: 12-24 months (n = 20). Before treatment, groups 1 and 2 differed significantly from the others in height (p < 0.001). With hormone therapy, catch-up growth was observed in groups 3 to 5, but at age 5 years no differences were found between groups. In all groups, height at 5 years of age correlated significantly with children's midparental height (p < 0.002). Bone age was initially retarded in groups 3 to 5, but approximated the chronological age by age 5 years. Initially, HC was less affected than height and remained relatively larger up to age 5 years in all groups. These findings show that thyroid hormone replacement in CH as late as 24 months corrects the short stature and delayed bone age by age 5 years.
为了评估治疗年龄对随后的生长、身高、体重、头围(HC)和骨龄(Greulich-Pyle法和TW2-RUS法)的影响,研究了100名先天性甲状腺功能减退症(CH)患儿在治疗前和治疗期间(5岁前)的情况。根据患者开始治疗时的年龄分为5组:1组< 2个月(n = 26);第二组:2-3个月(n = 13);第三组:3 ~ 6个月(n = 21);第4组:6-12个月(n = 20);第5组:12-24个月(n = 20)。治疗前,1、2组患者身高差异有统计学意义(p < 0.001)。通过激素治疗,在第3至第5组观察到追赶生长,但在5岁时各组之间没有发现差异。各组儿童5岁身高与双亲身高均显著相关(p < 0.002)。骨龄在第3至第5组开始减慢,但在5岁时接近实足年龄。最初,HC受身高影响较小,并且在所有组中一直保持相对较大,直到5岁。这些研究结果表明,甲状腺激素替代治疗迟至24个月的CH可纠正身高矮小和延迟5岁的骨龄。
{"title":"Growth follow-up in 100 children with congenital hypothyroidism before and during treatment.","authors":"A Chiesa,&nbsp;L Gruñeiro de Papendieck,&nbsp;A Keselman,&nbsp;J J Heinrich,&nbsp;C Bergada","doi":"10.1515/jpem.1994.7.3.211","DOIUrl":"https://doi.org/10.1515/jpem.1994.7.3.211","url":null,"abstract":"In order to assess the influence of age at onset of treatment on subsequent growth, height, weight, head circumference (HC) and bone age as estimated by Greulich-Pyle and TW2-RUS methods, 100 children with congenital hypothyroidism (CH) were studied before and during adequate treatment up to 5 years of age. The patients were divided into five groups according to age at the start of treatment: Group 1: < 2 months (n = 26); Group 2: 2-3 months (n = 13); Group 3: 3-6 months (n = 21); Group 4: 6-12 months (n = 20); Group 5: 12-24 months (n = 20). Before treatment, groups 1 and 2 differed significantly from the others in height (p < 0.001). With hormone therapy, catch-up growth was observed in groups 3 to 5, but at age 5 years no differences were found between groups. In all groups, height at 5 years of age correlated significantly with children's midparental height (p < 0.002). Bone age was initially retarded in groups 3 to 5, but approximated the chronological age by age 5 years. Initially, HC was less affected than height and remained relatively larger up to age 5 years in all groups. These findings show that thyroid hormone replacement in CH as late as 24 months corrects the short stature and delayed bone age by age 5 years.","PeriodicalId":79383,"journal":{"name":"The Journal of pediatric endocrinology","volume":"7 3","pages":"211-7"},"PeriodicalIF":0.0,"publicationDate":"1994-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/jpem.1994.7.3.211","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18819149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 33
Prenatal diagnosis and treatment of congenital adrenal hyperplasia. 先天性肾上腺增生症的产前诊断与治疗。
Pub Date : 1994-07-01 DOI: 10.1515/jpem.1994.7.3.183
P W Speiser, M I New

Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is associated with hormonal imbalance which predisposes affected females to prenatal development of genital ambiguity. Because the disease is usually not lethal and can be treated with glucocorticoids, affected pregnancies are seldom terminated. Dexamethasone can be administered to the pregnant mother and is effective in correcting the fetus's adrenal hormone imbalance during gestation. Nearly a decade's experience with prenatal treatment of CAH indicates that the risk-benefit ratio is favorable for mother and fetus with careful medical supervision of gestationally administered dexamethasone.

21-羟化酶缺乏导致的先天性肾上腺增生(CAH)与激素失衡有关,激素失衡易使受影响的女性在产前出现生殖器模糊。由于这种疾病通常不是致命的,可以用糖皮质激素治疗,受影响的妊娠很少被终止。地塞米松可用于孕妇,对纠正妊娠期胎儿肾上腺激素失衡有效。近十年的CAH产前治疗经验表明,在妊娠期给予地塞米松的仔细医学监督下,风险-收益比对母亲和胎儿有利。
{"title":"Prenatal diagnosis and treatment of congenital adrenal hyperplasia.","authors":"P W Speiser,&nbsp;M I New","doi":"10.1515/jpem.1994.7.3.183","DOIUrl":"https://doi.org/10.1515/jpem.1994.7.3.183","url":null,"abstract":"<p><p>Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is associated with hormonal imbalance which predisposes affected females to prenatal development of genital ambiguity. Because the disease is usually not lethal and can be treated with glucocorticoids, affected pregnancies are seldom terminated. Dexamethasone can be administered to the pregnant mother and is effective in correcting the fetus's adrenal hormone imbalance during gestation. Nearly a decade's experience with prenatal treatment of CAH indicates that the risk-benefit ratio is favorable for mother and fetus with careful medical supervision of gestationally administered dexamethasone.</p>","PeriodicalId":79383,"journal":{"name":"The Journal of pediatric endocrinology","volume":"7 3","pages":"183-91"},"PeriodicalIF":0.0,"publicationDate":"1994-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/jpem.1994.7.3.183","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18820613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Endocrine studies in children with myelomeningocele. 脊髓脊膜膨出儿童的内分泌研究。
Pub Date : 1994-07-01 DOI: 10.1515/jpem.1994.7.3.219
L Perrone, D Del Gaizo, E D'Angelo, L Rea, G Di Manso, R Del Gado

Pituitary-hypothalamic abnormalities due to impaired cerebrospinal fluid circulation have long been recognized. The aim of this study was to assess pituitary, thyroid, adrenal, and gonadal function in 46 prepubertal (22 M and 24 F) and 10 pubertal (4 M and 6 F) subjects with myelomeningocele (MMC). Basal serum levels of FT3, FT4, TSH, PRL, LH, FSH, T or E2, cortisol, 17-OH-P and DHEA-S were measured by routine radio-immunoassay methods. Twenty-two prepubertal patients had a TRH test for TSH and PRL evaluation, and eight underwent a GnRH test. Three patients presented with precocious puberty. Six subjects had modest elevations of serum TSH together with normal free thyroid hormone levels. In three cases, TSH responses to TRH were significantly exaggerated and prolonged: in two patients, TSH responses were delayed. The mean basal plasma FSH level in females with ventriculo-peritoneal shunt was significantly higher than in controls. In six cases FSH responses to GnRH were significantly higher than in controls. Both basal and stimulated PRL levels were elevated in patients with shunts; in patients without shunts, basal PRL was normal, but peak PRL levels following TRH stimulation were elevated. Our data show an abnormal hypothalamic-pituitary function in MMC subjects. These findings reinforce the importance of physical examination, hormonal evaluation and follow-up of pubertal development in patients with myelomeningocele.

脑脊液循环受损引起的垂体-下丘脑异常早已被认识到。本研究的目的是评估46例青春期前(22 M和24 F)和10例青春期(4 M和6 F)脊髓脊膜膨出(MMC)患者的垂体、甲状腺、肾上腺和性腺功能。采用常规放射免疫法测定血清FT3、FT4、TSH、PRL、LH、FSH、T或E2、皮质醇、17-OH-P、DHEA-S的基础水平。22例青春期前患者进行了TSH和PRL评估的TRH测试,8例进行了GnRH测试。3例患者表现为性早熟。6名受试者血清TSH轻度升高,游离甲状腺激素水平正常。在三个病例中,TSH对TRH的反应明显夸大和延长;在两个患者中,TSH反应延迟。脑室-腹膜分流术女性的平均基础血浆卵泡刺激素水平明显高于对照组。在6例中,FSH对GnRH的反应明显高于对照组。分流术患者的基础PRL和刺激PRL水平均升高;在没有分流的患者中,基础PRL正常,但TRH刺激后的峰值PRL水平升高。我们的数据显示MMC受试者的下丘脑-垂体功能异常。这些发现加强了体格检查、激素评估和脊髓脊膜膨出患者青春期发育随访的重要性。
{"title":"Endocrine studies in children with myelomeningocele.","authors":"L Perrone,&nbsp;D Del Gaizo,&nbsp;E D'Angelo,&nbsp;L Rea,&nbsp;G Di Manso,&nbsp;R Del Gado","doi":"10.1515/jpem.1994.7.3.219","DOIUrl":"https://doi.org/10.1515/jpem.1994.7.3.219","url":null,"abstract":"<p><p>Pituitary-hypothalamic abnormalities due to impaired cerebrospinal fluid circulation have long been recognized. The aim of this study was to assess pituitary, thyroid, adrenal, and gonadal function in 46 prepubertal (22 M and 24 F) and 10 pubertal (4 M and 6 F) subjects with myelomeningocele (MMC). Basal serum levels of FT3, FT4, TSH, PRL, LH, FSH, T or E2, cortisol, 17-OH-P and DHEA-S were measured by routine radio-immunoassay methods. Twenty-two prepubertal patients had a TRH test for TSH and PRL evaluation, and eight underwent a GnRH test. Three patients presented with precocious puberty. Six subjects had modest elevations of serum TSH together with normal free thyroid hormone levels. In three cases, TSH responses to TRH were significantly exaggerated and prolonged: in two patients, TSH responses were delayed. The mean basal plasma FSH level in females with ventriculo-peritoneal shunt was significantly higher than in controls. In six cases FSH responses to GnRH were significantly higher than in controls. Both basal and stimulated PRL levels were elevated in patients with shunts; in patients without shunts, basal PRL was normal, but peak PRL levels following TRH stimulation were elevated. Our data show an abnormal hypothalamic-pituitary function in MMC subjects. These findings reinforce the importance of physical examination, hormonal evaluation and follow-up of pubertal development in patients with myelomeningocele.</p>","PeriodicalId":79383,"journal":{"name":"The Journal of pediatric endocrinology","volume":"7 3","pages":"219-23"},"PeriodicalIF":0.0,"publicationDate":"1994-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/jpem.1994.7.3.219","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18820617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
Secular changes in growth of Japanese children. 日本儿童成长的长期变化。
Pub Date : 1994-04-01 DOI: 10.1515/jpem.1994.7.2.163
M Takaishi
{"title":"Secular changes in growth of Japanese children.","authors":"M Takaishi","doi":"10.1515/jpem.1994.7.2.163","DOIUrl":"https://doi.org/10.1515/jpem.1994.7.2.163","url":null,"abstract":"","PeriodicalId":79383,"journal":{"name":"The Journal of pediatric endocrinology","volume":"7 2","pages":"163-73"},"PeriodicalIF":0.0,"publicationDate":"1994-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1515/jpem.1994.7.2.163","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19055620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 39
期刊
The Journal of pediatric endocrinology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1